Gene symbol: Crhr2

Also known as: Crf2r; CRF-R 2; CRH-R 2

Organism: Rattus norvegicus

Summary: Enables corticotropin-releasing hormone receptor activity and peptide hormone binding activity. Involved in several processes, including negative regulation of secretion; regulation of gene expression; and regulation of intracellular signal transduction. Located in several cellular components, including axon; cell body fiber; and perikaryon. Used to study colitis; ischemia; and muscular atrophy. Biomarker of colitis; functional colonic disease; irritable bowel syndrome; and mental depression. Human ortholog(s) of this gene implicated in asthma. Orthologous to human CRHR2 (corticotropin releasing hormone receptor 2). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 64680 Ensembl:ENSRNOG00000011145 AllianceGenome:RGD:70547


GO Annotation


Category Term ID Term description
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0002027 Regulation of heart rate
Process GO:0002791 Regulation of peptide secretion
Process GO:0002792 Negative regulation of peptide secretion
Process GO:0003008 System process
Process GO:0003013 Circulatory system process
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006576 Cellular biogenic amine metabolic process
Process GO:0006584 Catecholamine metabolic process
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006996 Organelle organization
Process GO:0007010 Cytoskeleton organization
Process GO:0007015 Actin filament organization
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007186 G protein-coupled receptor signaling pathway
Process GO:0007188 Adenylate cyclase-modulating G protein-coupled receptor signaling pathway
Process GO:0007205 Protein kinase C-activating G protein-coupled receptor signaling pathway
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007517 Muscle organ development
Process GO:0007519 Skeletal muscle tissue development
Process GO:0007586 Digestion
Process GO:0007600 Sensory perception
Process GO:0007610 Behavior
Process GO:0007631 Feeding behavior
Process GO:0008015 Blood circulation
Process GO:0008016 Regulation of heart contraction
Process GO:0008152 Metabolic process
Process GO:0008217 Regulation of blood pressure
Process GO:0009058 Biosynthetic process
Process GO:0009308 Amine metabolic process
Process GO:0009309 Amine biosynthetic process
Process GO:0009712 Catechol-containing compound metabolic process
Process GO:0009713 Catechol-containing compound biosynthetic process
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009755 Hormone-mediated signaling pathway
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010460 Positive regulation of heart rate
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010629 Negative regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010700 Negative regulation of norepinephrine secretion
Process GO:0010817 Regulation of hormone levels
Process GO:0010959 Regulation of metal ion transport
Process GO:0014060 Regulation of epinephrine secretion
Process GO:0014061 Regulation of norepinephrine secretion
Process GO:0014062 Regulation of serotonin secretion
Process GO:0014064 Positive regulation of serotonin secretion
Process GO:0014070 Response to organic cyclic compound
Process GO:0016043 Cellular component organization
Process GO:0016525 Negative regulation of angiogenesis
Process GO:0018958 Phenol-containing compound metabolic process
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019233 Sensory perception of pain
Process GO:0019438 Aromatic compound biosynthetic process
Process GO:0021536 Diencephalon development
Process GO:0021549 Cerebellum development
Process GO:0021761 Limbic system development
Process GO:0021854 Hypothalamus development
Process GO:0022037 Metencephalon development
Process GO:0022600 Digestive system process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030029 Actin filament-based process
Process GO:0030036 Actin cytoskeleton organization
Process GO:0030154 Cell differentiation
Process GO:0030855 Epithelial cell differentiation
Process GO:0030900 Forebrain development
Process GO:0030902 Hindbrain development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031960 Response to corticosteroid
Process GO:0032276 Regulation of gonadotropin secretion
Process GO:0032277 Negative regulation of gonadotropin secretion
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032675 Regulation of interleukin-6 production
Process GO:0032755 Positive regulation of interleukin-6 production
Process GO:0032811 Negative regulation of epinephrine secretion
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032872 Regulation of stress-activated MAPK cascade
Process GO:0032874 Positive regulation of stress-activated MAPK cascade
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0033604 Negative regulation of catecholamine secretion
Process GO:0033684 Regulation of luteinizing hormone secretion
Process GO:0033685 Negative regulation of luteinizing hormone secretion
Process GO:0033993 Response to lipid
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0035482 Gastric motility
Process GO:0040007 Growth
Process GO:0042221 Response to chemical
Process GO:0042401 Cellular biogenic amine biosynthetic process
Process GO:0042423 Catecholamine biosynthetic process
Process GO:0043269 Regulation of ion transport
Process GO:0043270 Positive regulation of ion transport
Process GO:0043271 Negative regulation of ion transport
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043434 Response to peptide hormone
Process GO:0043435 Response to corticotropin-releasing hormone
Process GO:0043949 Regulation of cAMP-mediated signaling
Process GO:0043950 Positive regulation of cAMP-mediated signaling
Process GO:0044057 Regulation of system process
Process GO:0044058 Regulation of digestive system process
Process GO:0044060 Regulation of endocrine process
Process GO:0044062 Regulation of excretion
Process GO:0044093 Positive regulation of molecular function
Process GO:0044106 Cellular amine metabolic process
Process GO:0044237 Cellular metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0045765 Regulation of angiogenesis
Process GO:0045777 Positive regulation of blood pressure
Process GO:0045823 Positive regulation of heart contraction
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0046189 Phenol-containing compound biosynthetic process
Process GO:0046676 Negative regulation of insulin secretion
Process GO:0046880 Regulation of follicle-stimulating hormone secretion
Process GO:0046882 Negative regulation of follicle-stimulating hormone secretion
Process GO:0046883 Regulation of hormone secretion
Process GO:0046888 Negative regulation of hormone secretion
Process GO:0048167 Regulation of synaptic plasticity
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048521 Negative regulation of behavior
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048589 Developmental growth
Process GO:0048630 Skeletal muscle tissue growth
Process GO:0048731 System development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0050433 Regulation of catecholamine secretion
Process GO:0050708 Regulation of protein secretion
Process GO:0050709 Negative regulation of protein secretion
Process GO:0050789 Regulation of biological process
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050795 Regulation of behavior
Process GO:0050796 Regulation of insulin secretion
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050806 Positive regulation of synaptic transmission
Process GO:0050877 Nervous system process
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051048 Negative regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051052 Regulation of DNA metabolic process
Process GO:0051054 Positive regulation of DNA metabolic process
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051091 Positive regulation of DNA-binding transcription factor activity
Process GO:0051092 Positive regulation of NF-kappaB transcription factor activity
Process GO:0051093 Negative regulation of developmental process
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051223 Regulation of protein transport
Process GO:0051224 Negative regulation of protein transport
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051384 Response to glucocorticoid
Process GO:0051716 Cellular response to stimulus
Process GO:0051924 Regulation of calcium ion transport
Process GO:0051926 Negative regulation of calcium ion transport
Process GO:0051952 Regulation of amine transport
Process GO:0051953 Negative regulation of amine transport
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060259 Regulation of feeding behavior
Process GO:0060291 Long-term synaptic potentiation
Process GO:0060322 Head development
Process GO:0060341 Regulation of cellular localization
Process GO:0060429 Epithelium development
Process GO:0060457 Negative regulation of digestive system process
Process GO:0060537 Muscle tissue development
Process GO:0060538 Skeletal muscle organ development
Process GO:0061061 Muscle structure development
Process GO:0061178 Regulation of insulin secretion involved in cellular response to glucose stimulus
Process GO:0061179 Negative regulation of insulin secretion involved in cellular response to glucose stimulus
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070201 Regulation of establishment of protein localization
Process GO:0070302 Regulation of stress-activated protein kinase signaling cascade
Process GO:0070304 Positive regulation of stress-activated protein kinase signaling cascade
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071375 Cellular response to peptide hormone stimulus
Process GO:0071376 Cellular response to corticotropin-releasing hormone stimulus
Process GO:0071383 Cellular response to steroid hormone stimulus
Process GO:0071384 Cellular response to corticosteroid stimulus
Process GO:0071385 Cellular response to glucocorticoid stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0080135 Regulation of cellular response to stress
Process GO:0090087 Regulation of peptide transport
Process GO:0090276 Regulation of peptide hormone secretion
Process GO:0090278 Negative regulation of peptide hormone secretion
Process GO:0090279 Regulation of calcium ion import
Process GO:0090281 Negative regulation of calcium ion import
Process GO:0097435 Supramolecular fiber organization
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:1901342 Regulation of vasculature development
Process GO:1901343 Negative regulation of vasculature development
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901362 Organic cyclic compound biosynthetic process
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901566 Organonitrogen compound biosynthetic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901615 Organic hydroxy compound metabolic process
Process GO:1901617 Organic hydroxy compound biosynthetic process
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903522 Regulation of blood circulation
Process GO:1903524 Positive regulation of blood circulation
Process GO:1903530 Regulation of secretion by cell
Process GO:1903531 Negative regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:1903828 Negative regulation of protein localization
Process GO:1904950 Negative regulation of establishment of protein localization
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000181 Negative regulation of blood vessel morphogenesis
Process GO:2000252 Negative regulation of feeding behavior
Process GO:2000278 Regulation of DNA biosynthetic process
Process GO:2000292 Regulation of defecation
Process GO:2000293 Negative regulation of defecation
Process GO:2000573 Positive regulation of DNA biosynthetic process
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005783 Endoplasmic reticulum
Component GO:0005791 Rough endoplasmic reticulum
Component GO:0005794 Golgi apparatus
Component GO:0005886 Plasma membrane
Component GO:0012505 Endomembrane system
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0030054 Cell junction
Component GO:0030424 Axon
Component GO:0030425 Dendrite
Component GO:0031224 Intrinsic component of membrane
Component GO:0036477 Somatodendritic compartment
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043196 Varicosity
Component GO:0043204 Perikaryon
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043679 Axon terminus
Component GO:0044297 Cell body
Component GO:0044304 Main axon
Component GO:0044306 Neuron projection terminus
Component GO:0045202 Synapse
Component GO:0070852 Cell body fiber
Component GO:0071944 Cell periphery
Component GO:0097447 Dendritic tree
Component GO:0098793 Presynapse
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0150034 Distal axon
Function GO:0001653 Peptide receptor activity
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0004930 G protein-coupled receptor activity
Function GO:0005102 Signaling receptor binding
Function GO:0005179 Hormone activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008528 G protein-coupled peptide receptor activity
Function GO:0015056 Corticotrophin-releasing factor receptor activity
Function GO:0017046 Peptide hormone binding
Function GO:0030545 Signaling receptor regulator activity
Function GO:0030546 Signaling receptor activator activity
Function GO:0033218 Amide binding
Function GO:0038023 Signaling receptor activity
Function GO:0042277 Peptide binding
Function GO:0042562 Hormone binding
Function GO:0043404 Corticotropin-releasing hormone receptor activity
Function GO:0048018 Receptor ligand activity
Function GO:0060089 Molecular transducer activity
Function GO:0098772 Molecular function regulator activity

Pathway annotation


Category Term ID Term description
RCTM RNO-162582 Signal Transduction
RCTM RNO-372790 Signaling by GPCR
RCTM RNO-373080 Class B/2 (Secretin family receptors)
RCTM RNO-500792 GPCR ligand binding
WikiPathways WP378 GPCRs, class B secretin-like
KEGG rno04024 cAMP signaling pathway
KEGG rno04080 Neuroactive ligand-receptor interaction
KEGG rno04934 Cushing syndrome

Expression profile of Crhr2 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 4.7534591
GSM2685202 MX2 tissue: Myocardium gender: female 5.31194595
GSM2685203 MX3 tissue: Myocardium gender: female 5.33091965
GSM2685204 MX4 tissue: Myocardium gender: male 5.36305155
GSM2685205 DZ1 tissue: Myocardium gender: male 4.9817526999999995
GSM2685206 DZ2 tissue: Myocardium gender: male 5.55304715
GSM2685207 DZ3 tissue: Myocardium gender: female 5.0473462
GSM2685208 DZ4 tissue: Myocardium gender: female 4.976705
GSM2685209 JJ1 tissue: Myocardium gender: male 5.372808
GSM2685210 JJ2 tissue: Myocardium gender: female 5.1514294
GSM2685211 JJ3 tissue: Myocardium gender: female 5.01382565
GSM2685212 JJ4 tissue: Myocardium gender: male 4.9450302
GSM2685213 NG1 tissue: Myocardium gender: male 5.1221264
GSM2685214 NG2 tissue: Myocardium gender: female 4.757618900000001
GSM2685215 NG3 tissue: Myocardium gender: male 4.9808660499999995
GSM2685216 NG4 tissue: Myocardium gender: female 5.3629701999999995
GSM2685217 YL1 tissue: Myocardium gender: male 4.29566735
GSM2685218 YL2 tissue: Myocardium gender: male 4.85493965
GSM2685219 YL3 tissue: Myocardium gender: female 4.9552306
GSM2685220 YL4 tissue: Myocardium gender: female 5.54419375
GSM2685221 QC1 tissue: Myocardium gender: male 5.2651995
GSM2685222 QC2 tissue: Myocardium gender: male 5.7452065
GSM2685223 QC3 tissue: Myocardium gender: female 5.2314266
GSM2685224 QC4 tissue: Myocardium gender: female 5.34020045

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.14907207
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.163820435
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.966226709
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.022230277
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.94759442
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.037699755

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.697332
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.240066
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.114301
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.369499
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.147305
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.868627

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.729
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 2.382
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 2.227
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 0.941
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 1.76

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 5.743887357
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 6.0696589575
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 5.566922541

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 236.0
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 169.4
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 155.4
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 151.5
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 171.8
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 203.2
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 138.7
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 147.6
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 163.8
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 77.7
GSM27494 CTL_a (control, 1st replicate) 212.5
GSM27495 CTL_b (control, 2nd replicate) 125.4
GSM27496 CTL_c (control, 3rd replicate) 80.5
GSM27497 CTL_d (control, 4th replicate) 184.0
GSM27498 CTL_e (control, 5th replicate) 179.6
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 141.8
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 163.8
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 157.8
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 138.7
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 194.7
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 665.7
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 52.4
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 185.8
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 119.3
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 28.9
GSM27509 ISCH_a (ischemia, 1st replicate) 203.7
GSM27510 ISCH_b (ischemia, 2nd replicate) 94.7
GSM27511 ISCH_c (ischemia, 3rd replicate) 125.7
GSM27512 ISCH_d (ischemia, 4th replicate) 165.9
GSM27513 ISCH_e (ischemia, 5th replicate) 224.0

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 183.1
GSM30791 baseline control 02 male, 275-300g 203.7
GSM30792 baseline control 03 male, 275-300g 168.1
GSM30793 baseline control 04 male, 275-300g 212.9
GSM30794 baseline control 05 male, 275-300g 142.6
GSM30795 baseline control 06 male, 275-300g 172.6
GSM30796 baseline control 07 male, 275-300g 141.4
GSM30797 baseline control 08 male, 275-300g 155.4
GSM30798 baseline control 09 male, 275-300g 325.8
GSM30799 pain 01 179.2
GSM30800 pain 02 217.6
GSM30801 pain 03 373.1
GSM30802 pain 04 173.2
GSM30803 pain 05 184.0
GSM30804 FC 01 218.8
GSM30805 FC 02 159.8
GSM30806 FC 03 181.7
GSM30807 FC 04 170.3
GSM30808 FC 05 145.8
GSM30809 IFC 01 151.2
GSM30810 IFC 02 186.2
GSM30811 IFC 03 108.3
GSM30812 IFC 04 129.5
GSM30813 IFC 05 193.5
GSM99800 isoflurane 01 male, 275-300g 120.3
GSM99801 isoflurane 02 male, 275-300g 200.2
GSM99802 isoflurane 03 male, 275-300g 235.5
GSM99803 isoflurane 04 male, 275-300g 172.3
GSM99804 isoflurane 05 male, 275-300g 108.8

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 6.9718
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 5.85985
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 5.6819500000000005
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 7.33305
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 6.98705
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 6.6179
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 6.41445
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 5.6726
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 6.1517

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 5.13223
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 5.10371
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 4.72926
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 5.08466
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 6.45438
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 6.52195
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 4.92946
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 4.72477
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 4.91455
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 4.12613
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 4.37178
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 4.46373
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 6.11845
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 4.8827
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 4.31972
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 4.45878

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.844988
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.011947
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.813863
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.938612
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.992766
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.824474
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.951012
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.98063
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.884793
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.845207
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.896378
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.840368
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.940619
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.894724
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.879717
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.911534
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.994424
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.969687
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.957257
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.953713
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.883794
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.94781
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.005487
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.998291
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.945106
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.901325
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.13059
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.967659
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.928377
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.023299
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.943114
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.958313
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.066938
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.911014
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.119042
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.017013
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.862901
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.018198
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.985235
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.950853
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.975988
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.036919
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.774272
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.920481
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.954676

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 5.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 5.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 9.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 4.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 3.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 3.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 3.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 3.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 10.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 6.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 2.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 5.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 8.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 8.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 6.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 6.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 5.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 5.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 2.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 3.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 12.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 3.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 2.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 3.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 4.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 9.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 8.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 4.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 5.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 2.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 6.0

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.0664
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0589
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.0938
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.0434
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.0991
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.0526
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.062
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.126
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0588
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.0589
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.147
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.0178

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 49.2
GSM5121 Isoflurane single exposure control-2 35.9
GSM5122 Isoflurane single exposure control-3 37.0
GSM5124 Isoflurane single exposure 1 hr-1 52.2
GSM5126 Isoflurane single exposure 1 hr-2 29.3
GSM5127 Isoflurane single exposure 2 hr-1 42.0
GSM5130 Isoflurane single exposure 2 hr-2 45.0
GSM5131 Isoflurane single exposure 2 hr-3 26.8

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.03139002
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.949734209
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.0967481315
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.9840362385
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.891177724
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.044148066
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.0764150205
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.972831892
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.975886148
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.736984757
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.0501133424999995
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.87384754
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.9377939275
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.1002351155
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.928864887
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.1039223635
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.0586933765
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.0560540005
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.0361916645
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.0445312975
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.054621474
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.0322215755
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.126159564
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.959156017

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.832625
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.660289
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.801749
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.818372
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.886298
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.959233
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.757746
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.77784
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.732781
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.793139
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.899922
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.6256
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.629564
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.914509
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.741848
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.820669
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.80959
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.712357
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.552421
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.742223
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.58781
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.751064
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.760848
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.750255

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 116.7592
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 163.0218

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 80.415197025
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 36.953850450000004
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 96.29135263500001
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 53.567106715
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 42.632153179999996
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 161.19545
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 104.26809366500001
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 91.184074195
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 58.22507077
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 78.239632505
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 58.71761705
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 120.91560415000001
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 87.85351888
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 67.650918765

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.03139002
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.949734209
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.0967481315
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.9840362385
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.891177724
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.044148066
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.0764150205
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.972831892
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.975886148
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.736984757
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.0501133424999995
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.87384754
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.9377939275
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.1002351155
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.928864887
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.1039223635
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.0586933765
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.0560540005
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.0361916645
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.0445312975
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.054621474
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.0322215755
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.126159564
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.959156017
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 80.415197025
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 36.953850450000004
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 96.29135263500001
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 53.567106715
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 42.632153179999996
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 161.19545
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 104.26809366500001
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 91.184074195
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 58.22507077
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 78.239632505
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 58.71761705
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 120.91560415000001
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 87.85351888
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 67.650918765

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 55.6
GSM5084 Control 2 61.2
GSM5085 Control 3 44.3
GSM5086 Control 4 59.5
GSM5087 Control 5 52.0
GSM5090 Control 6 47.5
GSM5105 Control 7 61.0
GSM5106 Control 8 45.2
GSM5107 Control 9 59.8
GSM5108 Halothane 10 exposure-1 47.2
GSM5109 Halothane 10 exposures-2 48.9
GSM5110 Halothane 10 exposures-3 50.3
GSM5111 Halothane 5 exposures-1 49.9
GSM5112 Halothane 5 exposures-2 54.7
GSM5113 Halothane 5 exposures-3 50.7
GSM5114 Isoflurane 10 exposures-1 40.0
GSM5115 Isoflurane 10 exposures-2 45.1
GSM5116 Isoflurane 10 exposures-3 34.9
GSM5117 Isoflurane 5 exposures-1 47.3
GSM5118 Isoflurane 5 exposures-2 64.6
GSM5119 Isoflurane 5 exposures-3 54.8
GSM11379 Control 10 64.8
GSM11380 Control 11 45.7
GSM11381 Control 12 54.7

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 16.79455
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 21.41555